Speciality: Oncology
Description:
A warm welcome to all medical professionals joining us for this insightful session: "Understanding the Evolution in Lung Cancer - An Initiative from Manipal Hospitals." Lung cancer treatment has undergone a remarkable transformation in recent years, moving from broad-spectrum therapies to highly precise, personalized approaches. Manipal Hospitals, at the forefront of medical innovation, is dedicated to integrating these advancements to offer cutting-edge care, improving patient outcomes and quality of life. This session, featuring renowned expert Dr. Lalit Sharma, will delve into the pivotal shifts in diagnostics, targeted therapies, immunotherapies, and surgical techniques that are redefining lung cancer management.
The journey of lung cancer treatment has seen significant breakthroughs, driven by a deeper understanding of the disease's molecular landscape. From early detection methods to the development of novel drugs that target specific genetic mutations, the evolution has been profound. Dr. Lalit Sharma will share his expertise on how these advancements, including precision medicine and innovative surgical procedures, are being effectively implemented at Manipal Hospitals. This initiative underscores Manipal's commitment to patient-centric care, ensuring that individuals receive tailored treatments based on their unique tumor characteristics, leading to more effective and less toxic interventions.
This webinar offers a comprehensive overview of the current best practices and future directions in lung cancer therapy. Attendees will gain valuable knowledge on the latest research, clinical trials, and multidisciplinary approaches that are crucial for optimizing patient care. Tune in to this session by Dr. Lalit Sharma and Manipal Hospitals to enhance your understanding of the dynamic field of lung cancer treatment and stay informed about the continuous progress in combating this challenging disease.
See More Webinars @ Hidoc Webinars
1.
In leukemia, allogeneic HCT is beneficial following primary induction failure.
2.
Team finds broken 'brake' on cancer mutation machine.
3.
Omega Fatty Acid Changes Tied to Lower Proliferation Rate in Early Prostate Cancer
4.
Prostate cancer screening program beneficial in top decile of polygenic risk score
5.
Talk About Medication Costs, Bringing Back Touch, and Understanding From Dish Tumors.
1.
New Research on Craniopharyngioma
2.
What Is May-Hegglin Anomaly? Understanding this Rare Blood Disorder
3.
A Closer Look at White Blood Cells in Urine: Uncovering the Causes and Treatments
4.
The Expanding Horizon of PSMA: A Comparative Clinical Review of Theranostics in Prostate Cancer and Beyond
5.
The Mysterious World of Petechiae: Exploring Causes and Treatments
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part VI
2.
A New Era in Managing Cancer-Associated Thrombosis
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V
4.
Navigating the Complexities of Ph Negative ALL - Part XV
5.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation